BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31515085)

  • 1. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.
    Cannatà A; Fabris E; Merlo M; Artico J; Gentile P; Pio Loco C; Ballaben A; Ramani F; Barbati G; Sinagra G
    Can J Cardiol; 2020 Jan; 36(1):37-44. PubMed ID: 31515085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.
    Halliday BP; Gulati A; Ali A; Newsome S; Lota A; Tayal U; Vassiliou VS; Arzanauskaite M; Izgi C; Krishnathasan K; Singhal A; Chiew K; Gregson J; Frenneaux MP; Cook SA; Pennell DJ; Collins P; Cleland JGF; Prasad SK
    Eur J Heart Fail; 2018 Oct; 20(10):1392-1400. PubMed ID: 29862606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.
    Fornaro A; Olivotto I; Rigacci L; Ciaccheri M; Tomberli B; Ferrantini C; Coppini R; Girolami F; Mazzarotto F; Chiostri M; Milli M; Marchionni N; Castelli G
    Eur J Heart Fail; 2018 May; 20(5):898-906. PubMed ID: 29148208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Dilated Cardiomyopathy in Children.
    Puggia I; Merlo M; Barbati G; Rowland TJ; Stolfo D; Gigli M; Ramani F; Di Lenarda A; Mestroni L; Sinagra G
    J Am Heart Assoc; 2016 Jun; 5(7):. PubMed ID: 27364989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.
    Eda Y; Nabeta T; Iikura S; Takigami Y; Fujita T; Iida Y; Ikeda Y; Ishii S; Ako J
    ESC Heart Fail; 2024 Jun; 11(3):1463-1471. PubMed ID: 38320776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling.
    Lapu-Bula R; Robert A; De Kock M; D'Hondt AM; Detry JM; Melin JA; Vanoverschelde JL
    Am J Cardiol; 1998 Sep; 82(6):779-85. PubMed ID: 9761090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History.
    Gentile P; Merlo M; Cannatà A; Gobbo M; Artico J; Stolfo D; Gigli M; Ramani F; Barbati G; Pinamonti B; Sinagra G
    J Am Heart Assoc; 2019 Sep; 8(17):e010705. PubMed ID: 31431100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.
    Merlo M; Cannatà A; Pio Loco C; Stolfo D; Barbati G; Artico J; Gentile P; De Paris V; Ramani F; Zecchin M; Gigli M; Pinamonti B; Korcova R; Di Lenarda A; Giacca M; Mestroni L; Camici PG; Sinagra G
    Eur J Heart Fail; 2020 Jul; 22(7):1111-1121. PubMed ID: 32452075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosis.
    Gigli M; Stolfo D; Merlo M; Barbati G; Ramani F; Brun F; Pinamonti B; Sinagra G
    Eur J Heart Fail; 2017 Apr; 19(4):531-539. PubMed ID: 27813212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction.
    Merlo M; Gentile P; Artico J; Cannatà A; Paldino A; De Angelis G; Barbati G; Alonge M; Gigli M; Pinamonti B; Ramani F; Zecchin M; Pirozzi F; Stolfo D; Sinagra G
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):343-350. PubMed ID: 30921270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: Clinical phenotyping and outcome correlates.
    Gentile P; Paldino A; Cannatà A; Artico J; Barbati G; Ramani F; Fabris E; Aleksova A; Stolfo D; Zecchin M; Merlo M; Sinagra G
    Int J Cardiol; 2019 Mar; 278():180-185. PubMed ID: 30416030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
    Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
    Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy.
    Lalario A; Del Mestre E; Lo Casto M; Nuzzi V; Manca P; Bromage DI; Barbati G; Merlo M; Sinagra G; Cannatà A
    ESC Heart Fail; 2022 Oct; 9(5):3052-3059. PubMed ID: 35735911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences.
    Vissing CR; Rasmussen TB; Dybro AM; Olesen MS; Pedersen LN; Jensen M; Bundgaard H; Christensen AH
    J Med Genet; 2021 Dec; 58(12):832-841. PubMed ID: 33106378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.
    Ciuca C; Ragni L; Hasan T; Balducci A; Angeli E; Prandstraller D; Egidy-Assenza G; Donti A; Bonvicini M; Gargiulo GD
    Future Cardiol; 2019 Mar; 15(2):95-107. PubMed ID: 30848673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry.
    Nuzzi V; Cannatà A; Manca P; Castrichini M; Barbati G; Aleksova A; Fabris E; Zecchin M; Merlo M; Boriani G; Sinagra G
    Int J Cardiol; 2021 Jan; 323():140-147. PubMed ID: 32853666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior restoration procedures and the long-term results in indicated patients with dilated cardiomyopathy †.
    Isomura T; Hirota M; Notomi Y; Hoshino J; Kondo T; Takahashi Y; Yoshida M
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):725-31; discussion 731. PubMed ID: 25736271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy.
    Siontis KC; Kim HM; Sharaf Dabbagh G; Latchamsetty R; Stojanovska J; Jongnarangsin K; Morady F; Bogun FM
    Heart Rhythm; 2017 Oct; 14(10):1487-1493. PubMed ID: 28603002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.